Protecting Innovation: How Biotech Leaders Can Reduce Downtime and Optimize System Performance
In biotech, time isn’t just money – it’s progress, regulatory momentum, and competitive edge. Yet many executive teams still underestimate how deeply network downtime and system performance issues can affect the systems housing their critical intellectual property (IP). Whether you’re managing terabytes of genomic data or running time-sensitive clinical trial software, performance lapses ripple across […]